tiprankstipranks
Trending News
More News >
Cymat Technologies Ltd (TSE:CYM)
:CYM
Canadian Market

Cymat Technologies (CYM) AI Stock Analysis

Compare
13 Followers

Top Page

TS

Cymat Technologies

(CYM)

Rating:53Neutral
Price Target:
C$0.00
▼(-100.00%Downside)
Cymat Technologies' overall score is driven by its challenging financial performance and valuation concerns. However, positive corporate events offer potential growth opportunities, slightly offsetting the financial risks. Technical analysis suggests mixed market sentiment, contributing to a moderate overall score.

Cymat Technologies (CYM) vs. iShares MSCI Canada ETF (EWC)

Cymat Technologies Business Overview & Revenue Model

Company DescriptionCymat Technologies Ltd. is a materials technology company operating in the advanced materials sector. It specializes in the production and commercialization of stabilized aluminum foam (SAF), a unique material known for its lightweight, energy absorption, and thermal conductivity properties. Cymat's core products are used across various industries, including automotive, architectural, and military applications, providing innovative solutions for design, safety, and efficiency challenges.
How the Company Makes MoneyCymat Technologies generates revenue primarily through the sale of its stabilized aluminum foam products. The company targets multiple industries, leveraging its technology to meet specific needs such as energy absorption in automotive crash management systems, acoustic and thermal insulation in architecture, and lightweight armor solutions for military applications. Key revenue streams include direct sales to manufacturers, as well as licensing agreements and partnerships that expand its market reach. Significant partnerships with industry leaders enhance Cymat's market presence and provide opportunities for collaborative product development, further driving sales and revenue growth.

Cymat Technologies Financial Statement Overview

Summary
Cymat Technologies is facing significant financial challenges, with negative equity, negative net income, and poor cash flow generation. Despite some revenue growth, the company remains in a precarious financial position with high leverage and operational challenges.
Income Statement
25
Negative
Cymat Technologies shows significant revenue volatility with a TTM revenue of $3.71M, reflecting a sharp increase compared to $1.62M in 2024, but still below the 2021 level of $4.15M. The company has persistent negative net income, with a TTM net loss of $2.92M. Gross profit margin has improved to 22.8% in the TTM period, but the net profit margin remains deeply negative at -78.5%. The EBIT and EBITDA margins are also negative, indicating operational challenges.
Balance Sheet
15
Very Negative
The balance sheet reveals financial instability, with negative equity of $4.91M in the TTM period. The debt-to-equity ratio is not meaningful due to negative equity, reflecting high leverage and risk. Total assets have declined, showing a concerning trend of asset erosion. The equity ratio is negative, which signifies a precarious financial position.
Cash Flow
20
Very Negative
Cymat Technologies struggles with cash flow generation, with a TTM operating cash flow of -$0.71M and free cash flow of -$0.74M. Although there's a reduction in negative free cash flow compared to the previous year, it remains a critical issue. The free cash flow to net income ratio is unfavorable, highlighting cash constraints.
BreakdownTTMJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income Statement
Total Revenue3.71M1.62M3.05M3.12M4.15M1.69M
Gross Profit848.24K-412.85K-270.42K795.48K2.12M373.27K
EBITDA-1.66M-3.36M-5.45M-4.23M252.17K-1.51M
Net Income-2.92M-4.27M-6.05M-4.75M-543.00K-1.81M
Balance Sheet
Total Assets2.84M3.96M4.16M6.17M6.58M1.86M
Cash, Cash Equivalents and Short-Term Investments55.49K56.27K324.05K2.47M5.02M251.58K
Total Debt4.79M2.94M2.28M1.02M1.10M1.06M
Total Liabilities7.74M6.78M4.77M3.83M3.71M2.75M
Stockholders Equity-4.91M-2.81M-612.07K2.34M2.88M-889.52K
Cash Flow
Free Cash Flow-744.03K-2.26M-3.49M-4.53M401.48K-1.38M
Operating Cash Flow-710.43K-2.23M-2.46M-4.32M432.92K-1.33M
Investing Cash Flow-33.60K-31.32K-1.03M-534.54K-31.44K-47.92K
Financing Cash Flow564.44K1.99M1.35M2.30M4.36M1.45M

Cymat Technologies Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.16
Price Trends
50DMA
0.12
Positive
100DMA
0.12
Positive
200DMA
0.12
Positive
Market Momentum
MACD
0.01
Negative
RSI
64.07
Neutral
STOCH
56.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CYM, the sentiment is Positive. The current price of 0.16 is above the 20-day moving average (MA) of 0.14, above the 50-day MA of 0.12, and above the 200-day MA of 0.12, indicating a bullish trend. The MACD of 0.01 indicates Negative momentum. The RSI at 64.07 is Neutral, neither overbought nor oversold. The STOCH value of 56.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:CYM.

Cymat Technologies Peers Comparison

Overall Rating
UnderperformOutperform
Sector (49)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
TSDRX
75
Outperform
C$222.58M4.7229.02%0.69%-19.66%15.33%
TSIVX
68
Neutral
C$3.53M31.254.29%4.99%112.84%
TSCYM
53
Neutral
C$11.17M78.34%81.96%42.19%
49
Neutral
C$2.91B2.04-80.91%2.67%12.55%-24.32%
TSIB
44
Neutral
C$6.87M34.86%
TSIP
30
Underperform
C$8.58M
-80.20%39.39%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:CYM
Cymat Technologies
0.16
0.00
0.00%
TSE:IP
ImagineAR
0.03
>-0.01
-14.29%
TSE:DRX
ADF Group Inc. SV
8.15
-7.29
-47.22%
TSE:IB
IBC Advanced Alloys
0.06
-0.01
-14.29%
TSE:IVX
Inventronics
0.72
0.04
5.88%

Cymat Technologies Corporate Events

Business Operations and Strategy
Cymat Technologies Secures 10-Year Partnership with NUVIA in Nuclear Sector
Positive
Apr 30, 2025

Cymat Technologies Ltd. has entered into a 10-year collaboration agreement with NUVIA, a French company in the nuclear energy sector, to integrate Cymat’s SmartMetal panels into NUVIA’s Nufoam systems. This partnership aims to enhance Cymat’s market presence in the nuclear industry, especially as nuclear energy gains traction as a low-carbon energy source. The agreement is expected to support Cymat’s revenue growth and strengthen its position in the industry, benefiting stakeholders through increased sales and joint marketing initiatives.

Private Placements and FinancingBusiness Operations and Strategy
Cymat Technologies Secures $1.3 Million Private Placement Approval
Positive
Apr 15, 2025

Cymat Technologies Ltd. has secured approval from the TSX Venture Exchange for a $1.3 million private placement financing. The funds will be used for capital equipment purchases and working capital, supporting a strategic business development initiative. This move is expected to enhance Cymat’s operational capabilities and strengthen its market position.

Private Placements and FinancingBusiness Operations and Strategy
Cymat Technologies Secures $1.3 Million in Private Placement Financing
Positive
Apr 9, 2025

Cymat Technologies Ltd. has successfully completed a non-brokered private placement financing, raising approximately $1.3 million. The funds will be used to purchase capital equipment supporting a major strategic business development initiative and to provide additional working capital for ongoing strategic automotive initiatives. This financing positions Cymat to capitalize on strategic opportunities and enhance its operational capabilities in the automotive sector.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 31, 2025